OctoPlus publishes prospectus for listing of shares issued on 18 December 2009
Click here to go to the webcast of OctoPlus' half-year results on Thursday 6 August at 10 AM CET
Click here to directly access OctoPlus' Annual Report 2008
OctoPlus has increased its fill & finish capacity by expanding its GMP facility
OctoPlus offers special formulation and manufacturing expertise in the following areas:
Our partners turn to OctoPlus for tailor-made pharmaceutical development, specialized expertise on formulation and for difficult-to-formulate compounds and extraordinary formulations.
For more information about our formulation development and clinical manufacturing services, please refer to our in-depth technical factsheets.